June 27, 2025
The American Gastroenterological Association (AGA) has issued an updated pragmatic review on sclerosing mesenteritis (SM). Published in Clinical Gastroenterology and Hepatology, the update evaluates available evidence for […]
June 27, 2025
TOPLINE: Adding salt to foods with a higher frequency was associated with increased risks for metabolic dysfunction-associated steatotic liver disease (MASLD), cirrhosis, and hepatocellular carcinoma. The […]
June 26, 2025
A new weight-loss compound targeting energy expenditure rather than appetite suppression showed early efficacy in a first-in-human study. The compound, SANA (MVD1; Eolo Pharma), activates creatine-dependent […]
June 26, 2025
(Reuters) -Altimmune shares cratered more than 50% on Thursday after its experimental obesity drug did not significantly improve liver scarring in patients with fatty liver disease […]
June 26, 2025
TOPLINE: A real-world analysis revealed that nearly half of the individuals starting semaglutide for weight management discontinued treatment within 5 months, with discontinuation patterns persisting even […]
June 24, 2025
Amycretin — a novel experimental molecular targeting both the glucagon-like peptide 1 (GLP-1) and the amylin receptor — has shown promise for weight management in early-phase […]
June 23, 2025
TOPLINE: In patients discharged after hospitalization for nonvariceal upper gastrointestinal (GI) bleeding, cigarette smoking is associated with a significantly increased risk for readmission for recurrent bleeding […]
June 23, 2025
The American College of Gastroenterology (ACG) has issued updated guidance on the management of Crohn’s disease (CD) that reflects the surge in development of therapeutic options […]
June 20, 2025
The European Medicines Agency (EMA) has recommended conditional marketing authorization for Rezdiffra (resmetirom) for adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced liver fibrosis. MASH […]